Mortality Associated With Influenza and Respiratory Syncytial Virus in the US, 1999-2018-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Mortality Associated With Influenza and Respiratory Syncytial Virus in the US, 1999-2018

Published:2022-02-28 Issue:2 Volume:5 Page:e220527
ISSN:2574-3805
Container-title:JAMA Network Open
language:en
Short-container-title:JAMA Netw Open

Author:

Hansen Chelsea L.¹²,Chaves Sandra S.³⁴,Demont Clarisse⁵,Viboud Cécile¹

Affiliation:

1. Division of International Epidemiology and Population Studies, Fogarty International Center, National Institutes of Health, Bethesda, Maryland

2. Brotman Baty Institute for Precision Medicine, University of Washington School of Medicine, Seattle

3. Department of Modeling, Epidemiology and Data Science, Sanofi Pasteur, Lyon, France

4. Foundation for Influenza Epidemiology, Fondation de France, Paris, France

5. Global RSV Medical Franchise Department, Sanofi Pasteur, Lyon, France

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2789446/hansen_2022_oi_220034_1645202343.63645.pdf

Reference47 articles.

1. Mortality associated with influenza and respiratory syncytial virus in the United States.;Thompson;JAMA,2003

2. Estimates of mortality attributable to influenza and RSV in the United States during 1997-2009 by influenza type or subtype, age, cause of death, and risk status.;Matias;Influenza Other Respir Viruses,2014

3. Medicaid expansion and infant mortality in the United States.;Bhatt;Am J Public Health,2018

Cited by 121 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunosenescence: A new direction in anti-aging research;International Immunopharmacology;2024-11

2. Cost-effectiveness of vaccinating adults aged 60 years and older against respiratory syncytial virus;Vaccine;2024-10

3. Safety and immunogenicity of mRNA-based seasonal influenza vaccines formulated to include multiple A/H3N2 strains with or without the B/Yamagata strain in US adults aged 50–75 years: a phase 1/2, open-label, randomised trial;The Lancet Infectious Diseases;2024-09

4. Respiratory syncytial virus infections in adults: a narrative review;The Lancet Respiratory Medicine;2024-09

5. New Vaccines for Chronic Respiratory Patients;Archivos de Bronconeumología;2024-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3